Endoscopic dilation and stenting for benign esophageal strictures
Bioinformation · 31.10.2026 · 22 (10) · 6889-6891
DOI: 10.6026/973206300226889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Prakash Chandra Mishra.
Abstract (Originalsprache)
Benign esophageal strictures (BES), arising from gastroesophageal reflux disease, caustic ingestion and radiation therapy, cause progressive dysphagia that impairs nutritional status and quality of life. Therefore, it is of interest to compare the endoscopic dilatation with SEMS placement in the management of BES, evaluating efficacy, safety and clinical outcomes. Endoscopic dilatation with balloon or bougie devices remains the first-line treatment, but frequent stricture recurrence necessitates repeated procedures and carries risks such as perforation. Self-expanding metal stents (SEMS) have emerged as an alternative for refractory or recurrent strictures, offering prolonged luminal patency and fewer interventions, although complications including stent migration, tissue overgrowth and difficult removal remain concerns. Primary endpoints include dysphagia relief, stricture recurrence, complication rates and patient-reported quality of life, with the aim of informing optimal management strategies for BES.
Zitieren
APA
Mishra, P. C. (2026). Endoscopic dilation and stenting for benign esophageal strictures. Bioinformation, 22(10), 6889-6891. https://doi.org/10.6026/973206300226889
Vancouver
Mishra PC. Endoscopic dilation and stenting for benign esophageal strictures. Bioinformation. 2026;22(10):6889-6891. doi:10.6026/973206300226889
BibTeX
@article{Mishra2026,
author = {Mishra, Prakash Chandra},
title = {Endoscopic dilation and stenting for benign esophageal strictures},
journal = {Bioinformation},
year = {2026},
volume = {22},
number = {10},
pages = {6889--6891},
doi = {10.6026/973206300226889}
}
EUVIMED